Goodwin GM, Haddad PM, Ferrier IN, Aronson JK, Barnes T, Cipriani A, et al.
Evidence-based guidelines for treating bipolar disorder: Revised third edition
recommendations from the British Association for Psychopharmacology. J
Psychopharmacol 2016;30(6):495–553. https://www.ncbi.nlm.nih.gov/pubmed/26979387
Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, et al. Consensus
guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017.
Pharmacopsychiatry 2018;51(1-02):9–62. https://www.ncbi.nlm.nih.gov/pubmed/28910830
Malhi GS, Bassett D, Boyce P, Bryant R, Fitzgerald PB, Fritz K, et al. Royal
Australian and New Zealand College of Psychiatrists clinical practice guidelines for
mood disorders. Aust N Z J Psychiatry 2015;49(12):1087–206. https://www.ncbi.nlm.nih.gov/pubmed/26643054
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian
Network for Mood and Anxiety Treatments (CANMAT) and International Society for
Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar
disorder. Bipolar Disord 2018;20(2):97–170. https://www.ncbi.nlm.nih.gov/pubmed/29536616
